COMPANYAbout Us

Message

The 100-year lifespan era.
Maintain, regain and control your youth.

NUMT aims to develop cell medicines that promote rejuvenation amid a rapidly aging global population.

By promoting the prevention and treatment of diseases associated with aging, we will not only maintain a healthy lifestyle and reduce the burden of medical care and nursing care, but also contribute to the realization of a society in which everyone can age physically and mentally with peace of mind, by improving the socio-economic and working environment.
The name "NUMT" comes from mitochondria, which produce energy in mammals.
We will work with Toho University, Kyoto University, and others to promote the development of rejuvenating cell medicines, and strive to create a society full of health and vitality for not only humans but also pets.

About Us

Company name NUMT Co., Ltd.
Address 1-12-17 Hinode, Kawasaki-ku, Kawasaki-shi, Kanagawa-ken, 210-0824
Phone number +81-44-223-7180
Fax number +81-44-223-7260
Established December 2019
Officers
President and CEOPresident and CEOShinji Nakadouri
DirectorDirectorMasahiro Murakami
DirectorDirectorHiroyuki Udano
AuditorAuditorShohei Kamishiro
Collaborative researcher

Yoshinori Takei

Professor, Department of Cell Therapy, Faculty of Medicine, Toho University
NUMT patent inventor

Akira Hirasawa

Associate Professor, Department of PharmacoGenomics, Graduate School of Pharmaceutical Sciences, Kyoto University
Basic patent inventor
Business Description
  • Research and development of diagnosis, prevention and treatment for diseases and aging
  • Manufacture and sale of medical cells, biological products and genes, and development of medical systems using these cells and biological products
  • Holding seminars and other events related to human and animal medical care
  • Conducting tasks related to human and animal clinical research, and collecting and providing information

History

2019 NUMT Co., Ltd. was established.
Worked on the development and social implementation of "rejuvenating cell medicine" from Toho University and Kyoto University.
2020 Applied for a basic patent (cell medicine). Applied overseas in 2022, and was granted a domestic patent in 2023. Also applied for a related patent (cytokine).
2023 Received the first certification from Toho University as a "Company Utilizing Intellectual Property Originating from Toho University."

Access

About 6 minutes walk from Sangyo-doro Station on the Keikyu Daishi Line
■By bus
Rinko bus [Kawa 02] [Kawa 03] from JR Kawasaki Station to Dekino, about 20 minutes, get off at Dekino stop, about 3 minutes walk

Seeking Partners in Innovation

We are seeking partners to collaborate in the practical application of our rejuvenation cell therapy, currently under patent application in Japan and internationally (PCT).
We welcome inquiries from pharmaceutical companies, venture firms, research institutions, CDMO, and other life science-related organizations interested in partnering with us.

CONTACT US

For questions or consultations regarding NUMT’s rejuvenation cell therapy,
or inquiries related to Partner Recruitment, please contact us below.

Contact Us

PAGETOP